ATM kinase activity modulates ITCH E3-ubiquitin ligase activity

Oncogene

Volumn 33, Issue 9, 2014, Pages 1113-1123

  Santini, S ^a,b   Stagni, V ^a,b   Giambruno, R ^c   Fianco, G ^a,b   Di Benedetto, A ^d   Mottolese, M ^d   Pellegrini, M ^e   Barila D ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ataxia Telangiectasia; ATM kinase; c FLIP L; c Jun; ITCH E3 ubiquitin ligase; protein ubiquitination and degradation

Indexed keywords

ATM PROTEIN; FLICE INHIBITORY PROTEIN; PROTEIN ITCH; SERINE; STRESS ACTIVATED PROTEIN KINASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; ATAXIA TELANGIECTASIA; CELL CYCLE ARREST; CELL DEATH; CLINICAL FEATURE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALIA; ATAXIA TELANGIECTASIA; ERINACEIDAE; MUS;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE; CELL LINE, TUMOR; DNA DAMAGE; DNA-BINDING PROTEINS; HEK293 CELLS; HEP G2 CELLS; HEPATOCYTES; HUMANS; MICE; PROTO-ONCOGENE PROTEINS C-JUN; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84896702019     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.52     Document Type: Article

References (38)

1. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155-167.
2. Bhatti S, Kozlov S, Farooqi AA, Naqui A, Lavin MF, Khanna KK. ATM protein kinase: The linchpin of cellular defenses to stress. Cell Mol Life Sci 2011; 68: 2977-3006.
3. Matsuoka S, Ballif B, Smogorzewska A, McDonald Er, Hurov K, Luo JL et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316: 1160-1166.
4. Stokes MP, Rush J, MacNeill J, Min Ren J, Sprott K, Nardone J et al. Profiling of UV-induced ATM/ATR signaling pathways. Proc Natl Acad Sci USA 2007; 104: 19855-19860.
5. Mu J-J, Wang Y, Leng M, Zhang J, Yang T, Besusso D et al. A proteomic analysis of Ataxia Telangiectasia-mutated (ATM/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints. J Biol Chem 2007; 282: 17330-17334.
6. Cheng Q, Chen J. Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle 2010; 9: 172-178.
7. Winter M, Sombroek D, Dauth I, Moehlenbrink J, Scheuermann K, Crone J et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol 2008; 10: 812-824.
8. Moyal L, Lerenthal Y, Gana-Weisz M, Mass G, So S, Wang SY et al. Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol Cell 2011; 41: 529-542.
9. Bernassola F, Karin M, Ciechanover A, Melino G. The HECT family of E3 ubiquitin ligases: Multiple players in cancer development. Cancer Cell 2008; 14: 10-21.
10. Melino G, Gallagher E, Aqeilan RI, Knight RA, Peschiaroli A, Rossi M et al. Itch: A HECT-Type E3 ligase regulating immunity, skin and cancer. Cell Deah Differ 2008; 15: 1103-1112.
11. Kee Y, Huibregtse JM. Regulation of Catalytic activities of HECT ubiquitin ligases. Biochem Biophys Res Commun 2007; 354: 329-333.
12. Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 2004; 306: 271-275.
13. Gallagher E, Gao M, Liu YC, Karin M. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc Natl Acad Sci USA 2006; 103: 1717-1722.
14. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006; 124: 601-613.
15. Yu JW, Shi Y. FLIP and death effector domain family. Oncogene 2008; 27: 6216-6227.
16. Stagni V, di Bari MG, Condo I, Cursi S, Testi R, Larenthal Y et al. ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells. Blood 2008; 111: 829-837.
17. Stagni V, Mingardi M, Santini S, Giaccari D, Barilà D. ATM kinase activity modulates cFLIP protein levels: Potential interplay between DNA damage signalling and TRAIL-induced apoptosis. Carcinogenesis 2010; 31: 1956-1963.
18. Mouchantaf R, Azakir BA, McPherson PS, Millard SM, Wood SA. The Ubiquitin Ligase ITCH is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X. J Biol Chem 2006; 281: 38738-38747.
19. Mund T, Pelham HR. Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins. EMBO Rep 2009; 10: 501-507.
20. Di Marcotullio L, Greco A, Mazzà D, Canettieri G, Pietrosanti L, Infante P et al. Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal. Oncogene 2011; 30: 65-76.
21. Rossi M, De Laurenzi V, Munarriz E, Green DR, Liu YC, Vousden KH et al. The ubiquitin-protein ligase Itch regulates p73 stability. Embo J. 2005; 24: 836-848.
22. Gilot D, Serandour AL, Ilyin GP, Lagadic-Gossmann D, Loyer P, Corlu A et al. A role for caspase-8 and c-FLIPL in proliferation and cell-cycle progression of primary hepatocytes. Carcinogenesis 2005; 26: 2086-2094.
23. Yang C, Zhou W, Jeon MS, Demydenko D, Harada Y, Zhou H et al. Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation. Mol Cell 2006; 21: 135-141.
24. Gao B, Lee SM, Fang D. The tyrosine kinase c-Abl protects c-Jun from ubiquitination-mediated degradation in T cells. J Biol Chem 2006; 281: 29711-29718.
25. Lens SM, Kataoka T, Fortner KA, Tinel A, Ferrero I, MacDonald RH et al. The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 2002; 22: 5419-5433.
26. Weizman N, Shiloh Y, Barzilai A. Contribution of the Atm protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in Atm-deficient brains. J Biol Chem 2003; 278: 6741-6747.
27. Bar-Shira A, Rashi-Elkeles S, Zlochover L, Moyal L, Smorodinsky NI, Seger R et al. ATM-dependent activation of the gene encoding MAP kinase phosphatase 5 by radiomimetic DNA damage. Oncogene 2002; 21: 849-855.
28. Schattemberg JM, Zimmermann T, Worns M, Sprinzl MF, Kreft A, Kohl T et al. Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo. J Hepatology 2011; 55: 1272-1280.
29. Daugherity EK, Balmus G, Al Saei A, Moore ES, Abi Abdallah D, Rogers AB et al. The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-Alcoholic fatty liver disease. Cell Cycle 2012; 11: 1918-1928.
30. Liu Y-C. The E3 ubiquitin ligase Itch in T cell activation, differentiation, and tolerance. Semin Immunol 2007; 19: 197-205.
31. Matei IR, Guidos CJ, Danska JS. ATM-dependent DNA damage surveillance in T-cell development and leukemogenesis: The DSB connection. Immunol Rev 2006; 209: 142-158.
32. Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: Tumours, embryos and stem cells. Nat Rev Cancer 2002; 2: 361-372.
33. Di Marcotullio L, Ferretti E, Greco A, De Smaele E, Po A, Sico MA et al. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat Cell Biol 2006; 8: 1415-1423.
34. Biton S, Dar I, Mittelman L, Pereg Y, Barzilai A, Shiloh Y. Nuclear ataxia-Telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells. J Biol Chem 2006; 281: 17482-17491.
35. Mongiardi P, Stagni V, Natoli M, Giaccari D, D'Agnano I, Falchetti M et al. Oxygen sensing is impaired in ATM defective cells. Cell Cycle 2011; 10: 4311-4320.
36. Hansen TM, Rossi M, Roperch JP, Ansell K, Simpson K, Taylor D et al. Itch inhibition regulates chemosensitivity in vitro. Biochem Biophys Res Commun 2007; 361: 33-36.
37. Ganten TM, Haas TL, Sykora J, Stahl H, Sprick MR, Fas SC et al. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death Differ 2004; 11(Suppl 1): S86-S96.
38. Barilà D, Rufini A, Condò I, Ventura N, Dorey K, Superti-Furga G et al. Caspase-dependent cleavage of c-Abl contributes to apoptosis. Mol Cell Biol 2003; 23: 2790-2799.